The Sound of Music21 Mar 2024 15:24
CERN, CHUV AND THERYQ JOIN FORCES FOR A
WORLD FIRST IN CANCER RADIOTHERAPY
CERN, the Lausanne University Hospital (CHUV) in Switzerland,
and THERYQ (ALCEN Group, France) signed an agreement
for the world-first development of a revolutionary FLASH
radiotherapy device that will use very high energy electron
(VHEE) radiation to treat cancers resistant to conventional
treatments.
The device will include a compact linear accelerator based on
CERN technology, and will use very high-energy electron beams
of 100 to 200 MeV, allowing cancers up to a depth of 20 cm to
be treated using the FLASH technique. It has the potential to
decrease the overall cost of treatment, and its compactness will
allow it to be used in a hospital setting. It will be based at CHUV
and is expected to be operational within two years, with the first
clinical trials planned for 2025.